PRO CHLORAX DIN 00636223
Health Canada record
| Active ingredient(s) | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 MG; CLIDINIUM BROMIDE 2.5 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | TARGETED SUBSTANCES (CDSA IV) |
| Class | Human |
| ATC | A03CA02 CLIDINIUM AND PSYCHOLEPTICS |
| Original market date | 31-Dec-1984 |
| Current status date | 23-Jul-2012 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pro Doc Limitée — licence 100182, currently licensed, last inspection rating C (2025-08-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CHLORDIAZEPOXIDE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00522996 | CHLORDIAZEPOXIDE | AA PHARMA INC | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 25 MG | Marketed |
| 00115630 | LIBRAX | BAUSCH HEALTH, CANADA INC. | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 MG; CLIDINIUM BROMIDE 2.5 MG | Marketed |
| 00618454 | CHLORAX | AA PHARMA INC | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 MG; CLIDINIUM BROMIDE 2.5 MG | Dormant |
| 00522988 | CHLORDIAZEPOXIDE | AA PHARMA INC | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 10 MG | Dormant |
| 00522724 | CHLORDIAZEPOXIDE | AA PHARMA INC | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 MG | Dormant |
| 00156590 | CHLORDIAZEPOXIDE CAP 10MG | PRO DOC LIMITEE | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 00363596 | CHLORDIAZEPOXIDE CAP 5MG | PRO DOC LIMITEE | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 00448737 | CHLORDIAZEPOXYDE 25 CAP | DUCHESNAY INC | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 00430935 | CHLORDIAZEPOXYDE CAP 10MG | DUCHESNAY INC | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 00434426 | CHLORDIAZEPOXYDE HCL CAP 25MG | PRO DOC LIMITEE | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 00235873 | CORAX CAP 10MG | ICN CANADA LTD. | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 00267090 | CORAX CAP 25MG | ICN CANADA LTD. | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 00295051 | CORAX CAP 5MG | ICN CANADA LTD. | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 00391077 | CORIUM CAP | ICN CANADA LTD. | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 MG; CLIDINIUM BROMIDE 2.5 MG | Cancelled Post Market |
| 00134333 | MEDILIUM CAP 10 10MG | MEDIC LABORATORY LTÉE | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 00134325 | MEDILIUM CAP 5MG | MEDIC LABORATORY LTÉE | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 00020923 | NOVO-POXIDE 10MG | NOVOPHARM LIMITED | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 00020931 | NOVO-POXIDE 25MG | NOVOPHARM LIMITED | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 25 MG | Cancelled Post Market |
| 00020915 | NOVO-POXIDE 5MG | NOVOPHARM LIMITED | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02239110 | NU-CHLORAX CAPSULES USP | NU-PHARM INC | Capsule | CHLORDIAZEPOXIDE HYDROCHLORIDE 5 MG; CLIDINIUM BROMIDE 2.5 MG | Cancelled (Unreturned Annual) |
International API supply for CHLORDIAZEPOXIDE HYDROCHLORIDE
1 valid EDQM Certificates of Suitability from 1 holders. 3 active FDA Drug Master Files.
Request a quote for PRO CHLORAX